Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies

NCT00246103 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms, Advanced

Interventions

DRUG: Valproic acid
DRUG: Epirubicin
DRUG: 5-fluorouracil
DRUG: Cyclophosphamide.

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]